Compile Data Set for Download or QSAR
maximum 50k data
Found 140 with Last Name = 'buonfiglio' and Initial = 'r'
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50267626(AZ-11548415 | AZD-1080)
Affinity DataKi:  31nMAssay Description:Inhibition of recombinant full length human GSK3beta expressed in Sf21 insect cells using biotinylated-AAEELDSRAGS(PO3H2)PQL peptide as substrate pre...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetL-lactate dehydrogenase A chain(Homo sapiens (Human))
University Of Bologna

Curated by ChEMBL
LigandPNGBDBM50114409(CHEMBL3609809)
Affinity DataKi:  3.90E+4nMAssay Description:Inhibition of human liver purified lactate dehydrogenase-A using pyruvate as substrate assessed as disappearance of NADH fluorescenceMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetL-lactate dehydrogenase A chain(Homo sapiens (Human))
University Of Bologna

Curated by ChEMBL
LigandPNGBDBM50114409(CHEMBL3609809)
Affinity DataKi:  4.70E+4nMAssay Description:Inhibition of human liver purified lactate dehydrogenase-A using NADH as substrate assessed as disappearance of NADH fluorescenceMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
University Of Bologna

Curated by ChEMBL
LigandPNGBDBM50386758(CHEMBL2046893)
Affinity DataIC50:  2.40nMAssay Description:Inhibition of human ERG expressed in HEK cells by patch clamp assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
University Of Bologna

Curated by ChEMBL
LigandPNGBDBM50386758(CHEMBL2046893)
Affinity DataIC50:  2.51nMAssay Description:Inhibition of human ERG expressed in HEK cells by patch clamp assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540739(CHEMBL4632807 | US11472795, Example 1)
Affinity DataIC50:  4nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540741(CHEMBL4640019)
Affinity DataIC50:  4nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540739(CHEMBL4632807 | US11472795, Example 1)
Affinity DataIC50:  4nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540740(CHEMBL4643920 | US11472795, Example 3)
Affinity DataIC50:  4.5nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540740(CHEMBL4643920 | US11472795, Example 3)
Affinity DataIC50:  6nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM577001(US11472795, Example 28)
Affinity DataIC50:  6nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540740(CHEMBL4643920 | US11472795, Example 3)
Affinity DataIC50:  6nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 alpha(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540741(CHEMBL4640019)
Affinity DataIC50: <10nMAssay Description:Inhibition of human recombinant GSK3alpha using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate incubated for 60 mins in presence of ATP at Km concentra...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540741(CHEMBL4640019)
Affinity DataIC50: <10nMAssay Description:Inhibition of human DYRK1A in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase Lyn(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540741(CHEMBL4640019)
Affinity DataIC50: <10nMAssay Description:Inhibition of human LynB using His-tagged Rb truncated protein as substrate incubated for 30 mins in presence of ATP at Km concentration by HTRF assa...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetBeta-adrenergic receptor kinase 1(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540741(CHEMBL4640019)
Affinity DataIC50:  11nMAssay Description:Inhibition of human GRK2 in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM576984(US11472795, Example 11)
Affinity DataIC50:  12nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDual specificity protein kinase CLK1(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540741(CHEMBL4640019)
Affinity DataIC50:  13nMAssay Description:Inhibition of human CLK1 in presence of ATPMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM576999(US11472795, Example 27)
Affinity DataIC50:  13nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540737(CHEMBL4633136 | US11472795, Example 10)
Affinity DataIC50:  14nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540729(CHEMBL4641082 | US11472795, Example 7)
Affinity DataIC50:  14nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540729(CHEMBL4641082 | US11472795, Example 7)
Affinity DataIC50:  14nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540737(CHEMBL4633136 | US11472795, Example 10)
Affinity DataIC50:  14nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM576981(US11472795, Example 9)
Affinity DataIC50:  15nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
University Of Bologna

Curated by ChEMBL
LigandPNGBDBM50386755(CHEMBL2046889)
Affinity DataIC50:  15.8nMAssay Description:Inhibition of human ERG expressed in HEK cells by patch clamp assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM576975(US11472795, Example 5)
Affinity DataIC50:  16nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM576990(US11472795, Example 17)
Affinity DataIC50:  17nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM576976(US11472795, Example 6)
Affinity DataIC50:  17nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
University Of Bologna

Curated by ChEMBL
LigandPNGBDBM50386755(CHEMBL2046889)
Affinity DataIC50:  17nMAssay Description:Inhibition of human ERG expressed in HEK cells by patch clamp assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM576974(US11472795, Example 4)
Affinity DataIC50:  17nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50134187(CHEMBL3735506 | US11472795, Example C | US9611249,...)
Affinity DataIC50:  18nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM576993(US11472795, Example 20)
Affinity DataIC50:  18.5nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540730(CHEMBL4635680 | US11472795, Example 12)
Affinity DataIC50:  20nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540730(CHEMBL4635680 | US11472795, Example 12)
Affinity DataIC50:  20nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50134187(CHEMBL3735506 | US11472795, Example C | US9611249,...)
Affinity DataIC50:  21.6nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540738(CHEMBL4638321 | US11472795, Example 23)
Affinity DataIC50:  22nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540733(CHEMBL4633727)
Affinity DataIC50:  22nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540738(CHEMBL4638321 | US11472795, Example 23)
Affinity DataIC50:  22nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM576989(US11472795, Example 16)
Affinity DataIC50:  23nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540731(CHEMBL4634867 | US11472795, Example 15)
Affinity DataIC50:  26nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540731(CHEMBL4634867 | US11472795, Example 15)
Affinity DataIC50:  26nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCyclin-A2/Cyclin-dependent kinase 2(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540741(CHEMBL4640019)
Affinity DataIC50:  27nMAssay Description:Inhibition of human CDK2/cyclinA using Ulight-CFFKNIVTPRTPPPSQGK-amide as substrate incubated for 30 mins in presence of ATP by LANCE assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540742(CHEMBL4636306 | US11472795, Example 22)
Affinity DataIC50:  28nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540742(CHEMBL4636306 | US11472795, Example 22)
Affinity DataIC50:  28nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540734(CHEMBL4633607)
Affinity DataIC50:  31nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM576980(US11472795, Example 8)
Affinity DataIC50:  32nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540743(CHEMBL4641148 | US11472795, Example 18)
Affinity DataIC50:  33nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540743(CHEMBL4641148 | US11472795, Example 18)
Affinity DataIC50:  33nMAssay Description:The activity on human GSK-3β of the compounds of the invention listed in the following Table 1 and of the comparison compound C was assessed at ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGlycogen synthase kinase-3 beta(Homo sapiens (Human))
Angelini Pharma

Curated by ChEMBL
LigandPNGBDBM50540736(CHEMBL4645145)
Affinity DataIC50:  39nMAssay Description:Inhibition of recombinant full length human N-terminal GST-tagged GSK3beta (1 to 420 end residues) expressed in baculovirus expression system using u...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetPotassium voltage-gated channel subfamily H member 2(Homo sapiens (Human))
University Of Bologna

Curated by ChEMBL
LigandPNGBDBM50386757(CHEMBL2046892)
Affinity DataIC50:  39.8nMAssay Description:Inhibition of human ERG expressed in HEK cells by patch clamp assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 140 total ) | Next | Last >>
Jump to: